nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—SLC6A4—Alzheimer's disease	0.128	0.405	CbGaD
Desipramine—HTR2A—Alzheimer's disease	0.0984	0.311	CbGaD
Desipramine—CYP2D6—Alzheimer's disease	0.09	0.284	CbGaD
Desipramine—SLC22A2—Memantine—Alzheimer's disease	0.0735	0.179	CbGbCtD
Desipramine—HTR2A—Donepezil—Alzheimer's disease	0.0639	0.156	CbGbCtD
Desipramine—CYP2A6—Memantine—Alzheimer's disease	0.0586	0.143	CbGbCtD
Desipramine—DRD2—Memantine—Alzheimer's disease	0.051	0.125	CbGbCtD
Desipramine—CYP2B6—Memantine—Alzheimer's disease	0.0381	0.0931	CbGbCtD
Desipramine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0266	0.0648	CbGbCtD
Desipramine—CYP2C19—Memantine—Alzheimer's disease	0.0242	0.0591	CbGbCtD
Desipramine—CYP2D6—Donepezil—Alzheimer's disease	0.0212	0.0518	CbGbCtD
Desipramine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0169	0.0412	CbGbCtD
Desipramine—CYP2D6—Galantamine—Alzheimer's disease	0.0137	0.0334	CbGbCtD
Desipramine—CYP3A4—Donepezil—Alzheimer's disease	0.0135	0.033	CbGbCtD
Desipramine—CYP3A4—Galantamine—Alzheimer's disease	0.00871	0.0212	CbGbCtD
Desipramine—HTR2C—choroid plexus—Alzheimer's disease	0.00673	0.11	CbGeAlD
Desipramine—SLC6A2—locus ceruleus—Alzheimer's disease	0.00347	0.0567	CbGeAlD
Desipramine—HTR2A—choroid plexus—Alzheimer's disease	0.00338	0.0551	CbGeAlD
Desipramine—HTR2A—locus ceruleus—Alzheimer's disease	0.00209	0.0341	CbGeAlD
Desipramine—SLC6A3—telencephalic ventricle—Alzheimer's disease	0.00204	0.0333	CbGeAlD
Desipramine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00197	0.0322	CbGeAlD
Desipramine—HTR2A—cerebellar cortex—Alzheimer's disease	0.0017	0.0278	CbGeAlD
Desipramine—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00166	0.0271	CbGeAlD
Desipramine—DRD2—telencephalic ventricle—Alzheimer's disease	0.0015	0.0245	CbGeAlD
Desipramine—SMPD1—forebrain—Alzheimer's disease	0.00117	0.0191	CbGeAlD
Desipramine—SMPD1—telencephalon—Alzheimer's disease	0.00108	0.0176	CbGeAlD
Desipramine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.00099	0.0162	CbGeAlD
Desipramine—Numbness—Memantine—Alzheimer's disease	0.000879	0.00715	CcSEcCtD
Desipramine—Nocturia—Donepezil—Alzheimer's disease	0.000865	0.00704	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Galantamine—Alzheimer's disease	0.000864	0.00703	CcSEcCtD
Desipramine—Sensory loss—Memantine—Alzheimer's disease	0.000841	0.00684	CcSEcCtD
Desipramine—Vascular purpura—Galantamine—Alzheimer's disease	0.00084	0.00684	CcSEcCtD
Desipramine—Atrioventricular block—Donepezil—Alzheimer's disease	0.000827	0.00673	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Donepezil—Alzheimer's disease	0.000802	0.00653	CcSEcCtD
Desipramine—Purpura—Galantamine—Alzheimer's disease	0.00078	0.00634	CcSEcCtD
Desipramine—Nocturia—Rivastigmine—Alzheimer's disease	0.000768	0.00625	CcSEcCtD
Desipramine—Cerebrovascular accident—Galantamine—Alzheimer's disease	0.000767	0.00624	CcSEcCtD
Desipramine—Atrioventricular block—Memantine—Alzheimer's disease	0.000751	0.00611	CcSEcCtD
Desipramine—Disturbance in sexual arousal—Galantamine—Alzheimer's disease	0.000745	0.00607	CcSEcCtD
Desipramine—Coordination abnormal—Memantine—Alzheimer's disease	0.000742	0.00604	CcSEcCtD
Desipramine—Atrioventricular block—Rivastigmine—Alzheimer's disease	0.000735	0.00598	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Memantine—Alzheimer's disease	0.000728	0.00593	CcSEcCtD
Desipramine—Coordination abnormal—Rivastigmine—Alzheimer's disease	0.000726	0.0059	CcSEcCtD
Desipramine—Urinary retention—Galantamine—Alzheimer's disease	0.000714	0.00581	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Rivastigmine—Alzheimer's disease	0.000713	0.0058	CcSEcCtD
Desipramine—Ataxia—Galantamine—Alzheimer's disease	0.000706	0.00575	CcSEcCtD
Desipramine—Nightmare—Memantine—Alzheimer's disease	0.000703	0.00572	CcSEcCtD
Desipramine—Nightmare—Rivastigmine—Alzheimer's disease	0.000688	0.0056	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Donepezil—Alzheimer's disease	0.000669	0.00545	CcSEcCtD
Desipramine—SMPD1—nervous system—Alzheimer's disease	0.000635	0.0104	CbGeAlD
Desipramine—Hyperkinesia—Memantine—Alzheimer's disease	0.000635	0.00517	CcSEcCtD
Desipramine—Libido decreased—Donepezil—Alzheimer's disease	0.000628	0.00511	CcSEcCtD
Desipramine—Hyperkinesia—Rivastigmine—Alzheimer's disease	0.000621	0.00506	CcSEcCtD
Desipramine—SMPD1—central nervous system—Alzheimer's disease	0.000612	0.00998	CbGeAlD
Desipramine—Blood alkaline phosphatase increased—Memantine—Alzheimer's disease	0.000608	0.00495	CcSEcCtD
Desipramine—Pollakiuria—Galantamine—Alzheimer's disease	0.0006	0.00488	CcSEcCtD
Desipramine—SMPD1—cerebellum—Alzheimer's disease	0.000598	0.00976	CbGeAlD
Desipramine—Blood alkaline phosphatase increased—Rivastigmine—Alzheimer's disease	0.000595	0.00484	CcSEcCtD
Desipramine—Cerebrovascular accident—Donepezil—Alzheimer's disease	0.000594	0.00484	CcSEcCtD
Desipramine—Disorientation—Memantine—Alzheimer's disease	0.000591	0.00481	CcSEcCtD
Desipramine—Vascular purpura—Memantine—Alzheimer's disease	0.000591	0.00481	CcSEcCtD
Desipramine—Vascular purpura—Rivastigmine—Alzheimer's disease	0.000578	0.00471	CcSEcCtD
Desipramine—Disturbance in sexual arousal—Donepezil—Alzheimer's disease	0.000578	0.0047	CcSEcCtD
Desipramine—Depression—Galantamine—Alzheimer's disease	0.000577	0.0047	CcSEcCtD
Desipramine—Libido decreased—Memantine—Alzheimer's disease	0.00057	0.00464	CcSEcCtD
Desipramine—Psychotic disorder—Donepezil—Alzheimer's disease	0.000569	0.00463	CcSEcCtD
Desipramine—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.000568	0.00462	CcSEcCtD
Desipramine—SLC22A3—embryo—Alzheimer's disease	0.000567	0.00926	CbGeAlD
Desipramine—Libido decreased—Rivastigmine—Alzheimer's disease	0.000558	0.00454	CcSEcCtD
Desipramine—Urinary retention—Donepezil—Alzheimer's disease	0.000554	0.00451	CcSEcCtD
Desipramine—Purpura—Memantine—Alzheimer's disease	0.000549	0.00446	CcSEcCtD
Desipramine—Ataxia—Donepezil—Alzheimer's disease	0.000548	0.00446	CcSEcCtD
Desipramine—CHRM4—nervous system—Alzheimer's disease	0.000541	0.00883	CbGeAlD
Desipramine—Cerebrovascular accident—Memantine—Alzheimer's disease	0.00054	0.00439	CcSEcCtD
Desipramine—Liver function test abnormal—Donepezil—Alzheimer's disease	0.000538	0.00437	CcSEcCtD
Desipramine—Purpura—Rivastigmine—Alzheimer's disease	0.000537	0.00437	CcSEcCtD
Desipramine—CHRM2—forebrain—Alzheimer's disease	0.000534	0.00872	CbGeAlD
Desipramine—SLC6A3—forebrain—Alzheimer's disease	0.000533	0.0087	CbGeAlD
Desipramine—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.000528	0.0043	CcSEcCtD
Desipramine—SLC22A1—forebrain—Alzheimer's disease	0.000525	0.00857	CbGeAlD
Desipramine—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.000524	0.00427	CcSEcCtD
Desipramine—CHRM4—central nervous system—Alzheimer's disease	0.000521	0.0085	CbGeAlD
Desipramine—Hepatitis—Galantamine—Alzheimer's disease	0.00052	0.00423	CcSEcCtD
Desipramine—Hallucination—Galantamine—Alzheimer's disease	0.000517	0.00421	CcSEcCtD
Desipramine—Psychotic disorder—Memantine—Alzheimer's disease	0.000516	0.0042	CcSEcCtD
Desipramine—HTR2C—forebrain—Alzheimer's disease	0.000515	0.00841	CbGeAlD
Desipramine—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.000513	0.00418	CcSEcCtD
Desipramine—ADRB1—forebrain—Alzheimer's disease	0.000506	0.00825	CbGeAlD
Desipramine—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.000505	0.00411	CcSEcCtD
Desipramine—Urinary retention—Memantine—Alzheimer's disease	0.000503	0.00409	CcSEcCtD
Desipramine—Eosinophilia—Donepezil—Alzheimer's disease	0.000498	0.00406	CcSEcCtD
Desipramine—Ataxia—Memantine—Alzheimer's disease	0.000497	0.00405	CcSEcCtD
Desipramine—Urinary retention—Rivastigmine—Alzheimer's disease	0.000492	0.004	CcSEcCtD
Desipramine—CHRM2—telencephalon—Alzheimer's disease	0.000491	0.00802	CbGeAlD
Desipramine—SLC6A3—telencephalon—Alzheimer's disease	0.00049	0.008	CbGeAlD
Desipramine—HTR2A—blood vessel—Alzheimer's disease	0.00049	0.008	CbGeAlD
Desipramine—SLC6A4—forebrain—Alzheimer's disease	0.000488	0.00797	CbGeAlD
Desipramine—Liver function test abnormal—Memantine—Alzheimer's disease	0.000488	0.00397	CcSEcCtD
Desipramine—CHRM1—forebrain—Alzheimer's disease	0.000486	0.00794	CbGeAlD
Desipramine—Ataxia—Rivastigmine—Alzheimer's disease	0.000486	0.00396	CcSEcCtD
Desipramine—SMPD1—brain—Alzheimer's disease	0.000486	0.00793	CbGeAlD
Desipramine—Tinnitus—Galantamine—Alzheimer's disease	0.000485	0.00394	CcSEcCtD
Desipramine—SLC22A1—telencephalon—Alzheimer's disease	0.000483	0.00788	CbGeAlD
Desipramine—Flushing—Galantamine—Alzheimer's disease	0.000482	0.00393	CcSEcCtD
Desipramine—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.000478	0.00389	CcSEcCtD
Desipramine—HTR2C—telencephalon—Alzheimer's disease	0.000474	0.00773	CbGeAlD
Desipramine—Pollakiuria—Donepezil—Alzheimer's disease	0.000465	0.00378	CcSEcCtD
Desipramine—ADRB1—telencephalon—Alzheimer's disease	0.000465	0.00759	CbGeAlD
Desipramine—Arrhythmia—Galantamine—Alzheimer's disease	0.000464	0.00378	CcSEcCtD
Desipramine—Weight increased—Donepezil—Alzheimer's disease	0.000458	0.00373	CcSEcCtD
Desipramine—SLC6A4—telencephalon—Alzheimer's disease	0.000449	0.00733	CbGeAlD
Desipramine—Depression—Donepezil—Alzheimer's disease	0.000447	0.00364	CcSEcCtD
Desipramine—CHRM1—telencephalon—Alzheimer's disease	0.000447	0.0073	CbGeAlD
Desipramine—Dysgeusia—Galantamine—Alzheimer's disease	0.000443	0.00361	CcSEcCtD
Desipramine—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000442	0.0036	CcSEcCtD
Desipramine—Myocardial infarction—Donepezil—Alzheimer's disease	0.00044	0.00358	CcSEcCtD
Desipramine—Jaundice—Donepezil—Alzheimer's disease	0.000437	0.00356	CcSEcCtD
Desipramine—CHRM3—forebrain—Alzheimer's disease	0.000435	0.00711	CbGeAlD
Desipramine—HTR1A—forebrain—Alzheimer's disease	0.000434	0.00708	CbGeAlD
Desipramine—SLC6A2—forebrain—Alzheimer's disease	0.00043	0.00702	CbGeAlD
Desipramine—Vision blurred—Galantamine—Alzheimer's disease	0.000426	0.00347	CcSEcCtD
Desipramine—Tremor—Galantamine—Alzheimer's disease	0.000424	0.00345	CcSEcCtD
Desipramine—CHRM5—nervous system—Alzheimer's disease	0.000423	0.0069	CbGeAlD
Desipramine—Pollakiuria—Memantine—Alzheimer's disease	0.000422	0.00344	CcSEcCtD
Desipramine—Erectile dysfunction—Memantine—Alzheimer's disease	0.000421	0.00342	CcSEcCtD
Desipramine—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00042	0.00342	CcSEcCtD
Desipramine—Weight increased—Memantine—Alzheimer's disease	0.000416	0.00338	CcSEcCtD
Desipramine—Agitation—Galantamine—Alzheimer's disease	0.000416	0.00338	CcSEcCtD
Desipramine—CHRM4—brain—Alzheimer's disease	0.000413	0.00675	CbGeAlD
Desipramine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000413	0.00336	CcSEcCtD
Desipramine—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000412	0.00335	CcSEcCtD
Desipramine—Malaise—Galantamine—Alzheimer's disease	0.000408	0.00332	CcSEcCtD
Desipramine—CHRM5—central nervous system—Alzheimer's disease	0.000407	0.00664	CbGeAlD
Desipramine—Weight increased—Rivastigmine—Alzheimer's disease	0.000407	0.00331	CcSEcCtD
Desipramine—Depression—Memantine—Alzheimer's disease	0.000406	0.00331	CcSEcCtD
Desipramine—Hepatitis—Donepezil—Alzheimer's disease	0.000403	0.00328	CcSEcCtD
Desipramine—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000402	0.00327	CcSEcCtD
Desipramine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000401	0.00326	CcSEcCtD
Desipramine—Hallucination—Donepezil—Alzheimer's disease	0.000401	0.00326	CcSEcCtD
Desipramine—CHRM3—telencephalon—Alzheimer's disease	0.0004	0.00654	CbGeAlD
Desipramine—Palpitations—Galantamine—Alzheimer's disease	0.0004	0.00325	CcSEcCtD
Desipramine—Myocardial infarction—Memantine—Alzheimer's disease	0.000399	0.00325	CcSEcCtD
Desipramine—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000399	0.00325	CcSEcCtD
Desipramine—HTR1A—telencephalon—Alzheimer's disease	0.000399	0.00651	CbGeAlD
Desipramine—Drowsiness—Rivastigmine—Alzheimer's disease	0.000399	0.00324	CcSEcCtD
Desipramine—Depression—Rivastigmine—Alzheimer's disease	0.000397	0.00323	CcSEcCtD
Desipramine—SLC6A2—telencephalon—Alzheimer's disease	0.000395	0.00645	CbGeAlD
Desipramine—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000393	0.0032	CcSEcCtD
Desipramine—Convulsion—Galantamine—Alzheimer's disease	0.000392	0.00319	CcSEcCtD
Desipramine—DRD2—forebrain—Alzheimer's disease	0.000392	0.0064	CbGeAlD
Desipramine—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000391	0.00318	CcSEcCtD
Desipramine—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000391	0.00318	CcSEcCtD
Desipramine—Hypertension—Galantamine—Alzheimer's disease	0.000391	0.00318	CcSEcCtD
Desipramine—Anxiety—Galantamine—Alzheimer's disease	0.000384	0.00312	CcSEcCtD
Desipramine—Discomfort—Galantamine—Alzheimer's disease	0.000381	0.0031	CcSEcCtD
Desipramine—Agranulocytosis—Memantine—Alzheimer's disease	0.00038	0.00309	CcSEcCtD
Desipramine—Dry mouth—Galantamine—Alzheimer's disease	0.000377	0.00307	CcSEcCtD
Desipramine—Tinnitus—Donepezil—Alzheimer's disease	0.000376	0.00306	CcSEcCtD
Desipramine—Confusional state—Galantamine—Alzheimer's disease	0.000372	0.00303	CcSEcCtD
Desipramine—Hepatitis—Memantine—Alzheimer's disease	0.000366	0.00298	CcSEcCtD
Desipramine—Hallucination—Memantine—Alzheimer's disease	0.000364	0.00296	CcSEcCtD
Desipramine—Hypoaesthesia—Memantine—Alzheimer's disease	0.000364	0.00296	CcSEcCtD
Desipramine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000362	0.00294	CcSEcCtD
Desipramine—Tachycardia—Galantamine—Alzheimer's disease	0.00036	0.00293	CcSEcCtD
Desipramine—DRD2—telencephalon—Alzheimer's disease	0.00036	0.00588	CbGeAlD
Desipramine—Arrhythmia—Donepezil—Alzheimer's disease	0.00036	0.00293	CcSEcCtD
Desipramine—Hepatitis—Rivastigmine—Alzheimer's disease	0.000358	0.00291	CcSEcCtD
Desipramine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000356	0.0029	CcSEcCtD
Desipramine—Hallucination—Rivastigmine—Alzheimer's disease	0.000356	0.0029	CcSEcCtD
Desipramine—Alopecia—Donepezil—Alzheimer's disease	0.000356	0.0029	CcSEcCtD
Desipramine—Anorexia—Galantamine—Alzheimer's disease	0.000352	0.00286	CcSEcCtD
Desipramine—Aprindine—CALM1—Alzheimer's disease	0.000346	0.074	CrCbGaD
Desipramine—Hypotension—Galantamine—Alzheimer's disease	0.000345	0.00281	CcSEcCtD
Desipramine—Dysgeusia—Donepezil—Alzheimer's disease	0.000343	0.00279	CcSEcCtD
Desipramine—Tinnitus—Memantine—Alzheimer's disease	0.000341	0.00278	CcSEcCtD
Desipramine—Dimetacrine—ACHE—Alzheimer's disease	0.000339	0.0726	CrCbGaD
Desipramine—Flushing—Memantine—Alzheimer's disease	0.000339	0.00276	CcSEcCtD
Desipramine—Insomnia—Galantamine—Alzheimer's disease	0.000334	0.00272	CcSEcCtD
Desipramine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000334	0.00271	CcSEcCtD
Desipramine—Flushing—Rivastigmine—Alzheimer's disease	0.000332	0.0027	CcSEcCtD
Desipramine—Paraesthesia—Galantamine—Alzheimer's disease	0.000332	0.0027	CcSEcCtD
Desipramine—Vision blurred—Donepezil—Alzheimer's disease	0.00033	0.00269	CcSEcCtD
Desipramine—Tremor—Donepezil—Alzheimer's disease	0.000329	0.00267	CcSEcCtD
Desipramine—Somnolence—Galantamine—Alzheimer's disease	0.000328	0.00267	CcSEcCtD
Desipramine—Arrhythmia—Memantine—Alzheimer's disease	0.000327	0.00266	CcSEcCtD
Desipramine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000325	0.00265	CcSEcCtD
Desipramine—Dyspepsia—Galantamine—Alzheimer's disease	0.000325	0.00265	CcSEcCtD
Desipramine—Alopecia—Memantine—Alzheimer's disease	0.000323	0.00263	CcSEcCtD
Desipramine—CHRM5—brain—Alzheimer's disease	0.000323	0.00527	CbGeAlD
Desipramine—Agitation—Donepezil—Alzheimer's disease	0.000322	0.00262	CcSEcCtD
Desipramine—CYP2A6—cerebellum—Alzheimer's disease	0.000321	0.00525	CbGeAlD
Desipramine—Decreased appetite—Galantamine—Alzheimer's disease	0.000321	0.00261	CcSEcCtD
Desipramine—ABCB1—blood vessel—Alzheimer's disease	0.000321	0.00524	CbGeAlD
Desipramine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00032	0.0026	CcSEcCtD
Desipramine—Fatigue—Galantamine—Alzheimer's disease	0.000318	0.00259	CcSEcCtD
Desipramine—Malaise—Donepezil—Alzheimer's disease	0.000316	0.00257	CcSEcCtD
Desipramine—Alopecia—Rivastigmine—Alzheimer's disease	0.000316	0.00257	CcSEcCtD
Desipramine—Constipation—Galantamine—Alzheimer's disease	0.000316	0.00257	CcSEcCtD
Desipramine—Dysgeusia—Memantine—Alzheimer's disease	0.000312	0.00254	CcSEcCtD
Desipramine—ORM1—nervous system—Alzheimer's disease	0.000311	0.00508	CbGeAlD
Desipramine—HRH1—forebrain—Alzheimer's disease	0.000309	0.00505	CbGeAlD
Desipramine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000305	0.00248	CcSEcCtD
Desipramine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000304	0.00248	CcSEcCtD
Desipramine—Convulsion—Donepezil—Alzheimer's disease	0.000304	0.00247	CcSEcCtD
Desipramine—Hypertension—Donepezil—Alzheimer's disease	0.000303	0.00246	CcSEcCtD
Desipramine—Vision blurred—Memantine—Alzheimer's disease	0.0003	0.00244	CcSEcCtD
Desipramine—ORM1—central nervous system—Alzheimer's disease	0.0003	0.00489	CbGeAlD
Desipramine—Tremor—Memantine—Alzheimer's disease	0.000298	0.00243	CcSEcCtD
Desipramine—Anxiety—Donepezil—Alzheimer's disease	0.000298	0.00242	CcSEcCtD
Desipramine—Ill-defined disorder—Memantine—Alzheimer's disease	0.000295	0.0024	CcSEcCtD
Desipramine—Discomfort—Donepezil—Alzheimer's disease	0.000295	0.0024	CcSEcCtD
Desipramine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000294	0.00239	CcSEcCtD
Desipramine—Agitation—Memantine—Alzheimer's disease	0.000293	0.00238	CcSEcCtD
Desipramine—HTR2A—embryo—Alzheimer's disease	0.000292	0.00477	CbGeAlD
Desipramine—Dry mouth—Donepezil—Alzheimer's disease	0.000292	0.00238	CcSEcCtD
Desipramine—Abdominal pain—Galantamine—Alzheimer's disease	0.000292	0.00238	CcSEcCtD
Desipramine—Body temperature increased—Galantamine—Alzheimer's disease	0.000292	0.00238	CcSEcCtD
Desipramine—Tremor—Rivastigmine—Alzheimer's disease	0.000292	0.00237	CcSEcCtD
Desipramine—CHRM2—nervous system—Alzheimer's disease	0.00029	0.00474	CbGeAlD
Desipramine—SLC6A3—nervous system—Alzheimer's disease	0.000289	0.00472	CbGeAlD
Desipramine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000289	0.00235	CcSEcCtD
Desipramine—Confusional state—Donepezil—Alzheimer's disease	0.000289	0.00235	CcSEcCtD
Desipramine—Malaise—Memantine—Alzheimer's disease	0.000287	0.00234	CcSEcCtD
Desipramine—Agitation—Rivastigmine—Alzheimer's disease	0.000286	0.00233	CcSEcCtD
Desipramine—Oedema—Donepezil—Alzheimer's disease	0.000286	0.00233	CcSEcCtD
Desipramine—SLC22A1—nervous system—Alzheimer's disease	0.000285	0.00465	CbGeAlD
Desipramine—HRH1—telencephalon—Alzheimer's disease	0.000285	0.00464	CbGeAlD
Desipramine—SLC22A4—cerebellum—Alzheimer's disease	0.000282	0.0046	CbGeAlD
Desipramine—Palpitations—Memantine—Alzheimer's disease	0.000281	0.00229	CcSEcCtD
Desipramine—Malaise—Rivastigmine—Alzheimer's disease	0.000281	0.00229	CcSEcCtD
Desipramine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00028	0.00228	CcSEcCtD
Desipramine—HTR2C—nervous system—Alzheimer's disease	0.00028	0.00457	CbGeAlD
Desipramine—CHRM2—central nervous system—Alzheimer's disease	0.000279	0.00456	CbGeAlD
Desipramine—SLC6A3—central nervous system—Alzheimer's disease	0.000279	0.00455	CbGeAlD
Desipramine—Convulsion—Memantine—Alzheimer's disease	0.000276	0.00225	CcSEcCtD
Desipramine—Palpitations—Rivastigmine—Alzheimer's disease	0.000275	0.00224	CcSEcCtD
Desipramine—Hypertension—Memantine—Alzheimer's disease	0.000275	0.00224	CcSEcCtD
Desipramine—ADRB1—nervous system—Alzheimer's disease	0.000274	0.00448	CbGeAlD
Desipramine—SLC22A1—central nervous system—Alzheimer's disease	0.000274	0.00448	CbGeAlD
Desipramine—CYP2E1—telencephalon—Alzheimer's disease	0.000273	0.00446	CbGeAlD
Desipramine—Anorexia—Donepezil—Alzheimer's disease	0.000273	0.00222	CcSEcCtD
Desipramine—SLC22A3—nervous system—Alzheimer's disease	0.000272	0.00445	CbGeAlD
Desipramine—SLC6A3—cerebellum—Alzheimer's disease	0.000272	0.00444	CbGeAlD
Desipramine—Anxiety—Memantine—Alzheimer's disease	0.00027	0.0022	CcSEcCtD
Desipramine—Convulsion—Rivastigmine—Alzheimer's disease	0.00027	0.0022	CcSEcCtD
Desipramine—HTR2C—central nervous system—Alzheimer's disease	0.000269	0.0044	CbGeAlD
Desipramine—Hypertension—Rivastigmine—Alzheimer's disease	0.000269	0.00219	CcSEcCtD
Desipramine—Discomfort—Memantine—Alzheimer's disease	0.000268	0.00218	CcSEcCtD
Desipramine—Hypotension—Donepezil—Alzheimer's disease	0.000267	0.00218	CcSEcCtD
Desipramine—SLC6A4—nervous system—Alzheimer's disease	0.000265	0.00433	CbGeAlD
Desipramine—Dry mouth—Memantine—Alzheimer's disease	0.000265	0.00216	CcSEcCtD
Desipramine—Asthenia—Galantamine—Alzheimer's disease	0.000265	0.00216	CcSEcCtD
Desipramine—Anxiety—Rivastigmine—Alzheimer's disease	0.000264	0.00215	CcSEcCtD
Desipramine—ADRB1—central nervous system—Alzheimer's disease	0.000264	0.00431	CbGeAlD
Desipramine—CHRM1—nervous system—Alzheimer's disease	0.000264	0.00431	CbGeAlD
Desipramine—SLC22A3—central nervous system—Alzheimer's disease	0.000262	0.00428	CbGeAlD
Desipramine—Confusional state—Memantine—Alzheimer's disease	0.000262	0.00213	CcSEcCtD
Desipramine—Discomfort—Rivastigmine—Alzheimer's disease	0.000262	0.00213	CcSEcCtD
Desipramine—CYP2A6—brain—Alzheimer's disease	0.000261	0.00426	CbGeAlD
Desipramine—Oedema—Memantine—Alzheimer's disease	0.00026	0.00211	CcSEcCtD
Desipramine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000259	0.00211	CcSEcCtD
Desipramine—Insomnia—Donepezil—Alzheimer's disease	0.000259	0.00211	CcSEcCtD
Desipramine—HTR2A—forebrain—Alzheimer's disease	0.000258	0.00422	CbGeAlD
Desipramine—Paraesthesia—Donepezil—Alzheimer's disease	0.000257	0.00209	CcSEcCtD
Desipramine—Confusional state—Rivastigmine—Alzheimer's disease	0.000256	0.00209	CcSEcCtD
Desipramine—SLC6A4—central nervous system—Alzheimer's disease	0.000255	0.00417	CbGeAlD
Desipramine—Somnolence—Donepezil—Alzheimer's disease	0.000254	0.00207	CcSEcCtD
Desipramine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000254	0.00207	CcSEcCtD
Desipramine—CHRM1—central nervous system—Alzheimer's disease	0.000254	0.00415	CbGeAlD
Desipramine—Oedema—Rivastigmine—Alzheimer's disease	0.000254	0.00207	CcSEcCtD
Desipramine—Tachycardia—Memantine—Alzheimer's disease	0.000254	0.00206	CcSEcCtD
Desipramine—Diarrhoea—Galantamine—Alzheimer's disease	0.000253	0.00206	CcSEcCtD
Desipramine—Dyspepsia—Donepezil—Alzheimer's disease	0.000252	0.00205	CcSEcCtD
Desipramine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000249	0.00203	CcSEcCtD
Desipramine—Decreased appetite—Donepezil—Alzheimer's disease	0.000249	0.00202	CcSEcCtD
Desipramine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000248	0.00202	CcSEcCtD
Desipramine—Anorexia—Memantine—Alzheimer's disease	0.000248	0.00202	CcSEcCtD
Desipramine—Fatigue—Donepezil—Alzheimer's disease	0.000247	0.00201	CcSEcCtD
Desipramine—Constipation—Donepezil—Alzheimer's disease	0.000245	0.00199	CcSEcCtD
Desipramine—Dizziness—Galantamine—Alzheimer's disease	0.000244	0.00199	CcSEcCtD
Desipramine—Hypotension—Memantine—Alzheimer's disease	0.000243	0.00198	CcSEcCtD
Desipramine—Anorexia—Rivastigmine—Alzheimer's disease	0.000242	0.00197	CcSEcCtD
Desipramine—HTR2A—telencephalon—Alzheimer's disease	0.000238	0.00388	CbGeAlD
Desipramine—Hypotension—Rivastigmine—Alzheimer's disease	0.000238	0.00193	CcSEcCtD
Desipramine—CHRM3—nervous system—Alzheimer's disease	0.000236	0.00386	CbGeAlD
Desipramine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000236	0.00192	CcSEcCtD
Desipramine—CYP2D6—forebrain—Alzheimer's disease	0.000235	0.00384	CbGeAlD
Desipramine—HTR1A—nervous system—Alzheimer's disease	0.000235	0.00384	CbGeAlD
Desipramine—Insomnia—Memantine—Alzheimer's disease	0.000235	0.00191	CcSEcCtD
Desipramine—Vomiting—Galantamine—Alzheimer's disease	0.000235	0.00191	CcSEcCtD
Desipramine—SLC6A2—nervous system—Alzheimer's disease	0.000233	0.00381	CbGeAlD
Desipramine—Paraesthesia—Memantine—Alzheimer's disease	0.000233	0.0019	CcSEcCtD
Desipramine—Rash—Galantamine—Alzheimer's disease	0.000233	0.00189	CcSEcCtD
Desipramine—Dermatitis—Galantamine—Alzheimer's disease	0.000233	0.00189	CcSEcCtD
Desipramine—Headache—Galantamine—Alzheimer's disease	0.000231	0.00188	CcSEcCtD
Desipramine—Somnolence—Memantine—Alzheimer's disease	0.000231	0.00188	CcSEcCtD
Desipramine—Insomnia—Rivastigmine—Alzheimer's disease	0.00023	0.00187	CcSEcCtD
Desipramine—SLC22A4—brain—Alzheimer's disease	0.000229	0.00373	CbGeAlD
Desipramine—Dyspepsia—Memantine—Alzheimer's disease	0.000229	0.00186	CcSEcCtD
Desipramine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000228	0.00186	CcSEcCtD
Desipramine—CHRM3—central nervous system—Alzheimer's disease	0.000228	0.00371	CbGeAlD
Desipramine—Urticaria—Donepezil—Alzheimer's disease	0.000227	0.00185	CcSEcCtD
Desipramine—HTR1A—central nervous system—Alzheimer's disease	0.000227	0.0037	CbGeAlD
Desipramine—Body temperature increased—Donepezil—Alzheimer's disease	0.000226	0.00184	CcSEcCtD
Desipramine—Abdominal pain—Donepezil—Alzheimer's disease	0.000226	0.00184	CcSEcCtD
Desipramine—Somnolence—Rivastigmine—Alzheimer's disease	0.000226	0.00184	CcSEcCtD
Desipramine—Decreased appetite—Memantine—Alzheimer's disease	0.000226	0.00184	CcSEcCtD
Desipramine—SLC6A2—central nervous system—Alzheimer's disease	0.000225	0.00367	CbGeAlD
Desipramine—Fatigue—Memantine—Alzheimer's disease	0.000224	0.00182	CcSEcCtD
Desipramine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000224	0.00182	CcSEcCtD
Desipramine—Constipation—Memantine—Alzheimer's disease	0.000222	0.00181	CcSEcCtD
Desipramine—CHRM2—brain—Alzheimer's disease	0.000222	0.00362	CbGeAlD
Desipramine—HTR1A—cerebellum—Alzheimer's disease	0.000222	0.00362	CbGeAlD
Desipramine—SLC6A3—brain—Alzheimer's disease	0.000221	0.00361	CbGeAlD
Desipramine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000221	0.0018	CcSEcCtD
Desipramine—Nausea—Galantamine—Alzheimer's disease	0.000219	0.00179	CcSEcCtD
Desipramine—Fatigue—Rivastigmine—Alzheimer's disease	0.000219	0.00178	CcSEcCtD
Desipramine—SLC22A1—brain—Alzheimer's disease	0.000218	0.00356	CbGeAlD
Desipramine—Constipation—Rivastigmine—Alzheimer's disease	0.000217	0.00177	CcSEcCtD
Desipramine—CYP2D6—telencephalon—Alzheimer's disease	0.000216	0.00353	CbGeAlD
Desipramine—Feeling abnormal—Memantine—Alzheimer's disease	0.000214	0.00174	CcSEcCtD
Desipramine—HTR2C—brain—Alzheimer's disease	0.000214	0.00349	CbGeAlD
Desipramine—DRD2—nervous system—Alzheimer's disease	0.000213	0.00347	CbGeAlD
Desipramine—ADRB1—brain—Alzheimer's disease	0.00021	0.00342	CbGeAlD
Desipramine—Amitriptyline—NTRK2—Alzheimer's disease	0.00021	0.0448	CrCbGaD
Desipramine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000209	0.0017	CcSEcCtD
Desipramine—SLC22A3—brain—Alzheimer's disease	0.000208	0.0034	CbGeAlD
Desipramine—Urticaria—Memantine—Alzheimer's disease	0.000206	0.00168	CcSEcCtD
Desipramine—Body temperature increased—Memantine—Alzheimer's disease	0.000205	0.00167	CcSEcCtD
Desipramine—Abdominal pain—Memantine—Alzheimer's disease	0.000205	0.00167	CcSEcCtD
Desipramine—Asthenia—Donepezil—Alzheimer's disease	0.000205	0.00167	CcSEcCtD
Desipramine—DRD2—central nervous system—Alzheimer's disease	0.000205	0.00334	CbGeAlD
Desipramine—SLC6A4—brain—Alzheimer's disease	0.000203	0.00331	CbGeAlD
Desipramine—Pruritus—Donepezil—Alzheimer's disease	0.000202	0.00165	CcSEcCtD
Desipramine—Urticaria—Rivastigmine—Alzheimer's disease	0.000202	0.00164	CcSEcCtD
Desipramine—CHRM1—brain—Alzheimer's disease	0.000202	0.0033	CbGeAlD
Desipramine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000201	0.00164	CcSEcCtD
Desipramine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000201	0.00164	CcSEcCtD
Desipramine—DRD2—cerebellum—Alzheimer's disease	0.0002	0.00327	CbGeAlD
Desipramine—Diarrhoea—Donepezil—Alzheimer's disease	0.000196	0.00159	CcSEcCtD
Desipramine—Benazepril—MTHFR—Alzheimer's disease	0.000192	0.0411	CrCbGaD
Desipramine—ABCB1—embryo—Alzheimer's disease	0.000191	0.00313	CbGeAlD
Desipramine—Dizziness—Donepezil—Alzheimer's disease	0.000189	0.00154	CcSEcCtD
Desipramine—Asthenia—Memantine—Alzheimer's disease	0.000186	0.00152	CcSEcCtD
Desipramine—SLC22A5—cerebellum—Alzheimer's disease	0.000186	0.00304	CbGeAlD
Desipramine—Pruritus—Memantine—Alzheimer's disease	0.000184	0.0015	CcSEcCtD
Desipramine—Asthenia—Rivastigmine—Alzheimer's disease	0.000182	0.00148	CcSEcCtD
Desipramine—Vomiting—Donepezil—Alzheimer's disease	0.000182	0.00148	CcSEcCtD
Desipramine—CHRM3—brain—Alzheimer's disease	0.000181	0.00295	CbGeAlD
Desipramine—Rash—Donepezil—Alzheimer's disease	0.00018	0.00147	CcSEcCtD
Desipramine—Dermatitis—Donepezil—Alzheimer's disease	0.00018	0.00147	CcSEcCtD
Desipramine—HTR1A—brain—Alzheimer's disease	0.00018	0.00294	CbGeAlD
Desipramine—Pruritus—Rivastigmine—Alzheimer's disease	0.00018	0.00146	CcSEcCtD
Desipramine—Headache—Donepezil—Alzheimer's disease	0.000179	0.00146	CcSEcCtD
Desipramine—SLC6A2—brain—Alzheimer's disease	0.000178	0.00291	CbGeAlD
Desipramine—Diarrhoea—Memantine—Alzheimer's disease	0.000178	0.00145	CcSEcCtD
Desipramine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000174	0.00142	CcSEcCtD
Desipramine—CYP2B6—nervous system—Alzheimer's disease	0.000172	0.00281	CbGeAlD
Desipramine—Dizziness—Memantine—Alzheimer's disease	0.000172	0.0014	CcSEcCtD
Desipramine—Nausea—Donepezil—Alzheimer's disease	0.00017	0.00138	CcSEcCtD
Desipramine—ABCB1—forebrain—Alzheimer's disease	0.000169	0.00276	CbGeAlD
Desipramine—Dizziness—Rivastigmine—Alzheimer's disease	0.000168	0.00137	CcSEcCtD
Desipramine—HRH1—nervous system—Alzheimer's disease	0.000168	0.00274	CbGeAlD
Desipramine—CYP2B6—central nervous system—Alzheimer's disease	0.000166	0.0027	CbGeAlD
Desipramine—Vomiting—Memantine—Alzheimer's disease	0.000165	0.00134	CcSEcCtD
Desipramine—Rash—Memantine—Alzheimer's disease	0.000164	0.00133	CcSEcCtD
Desipramine—Dermatitis—Memantine—Alzheimer's disease	0.000164	0.00133	CcSEcCtD
Desipramine—Headache—Memantine—Alzheimer's disease	0.000163	0.00132	CcSEcCtD
Desipramine—DRD2—brain—Alzheimer's disease	0.000163	0.00265	CbGeAlD
Desipramine—HRH1—central nervous system—Alzheimer's disease	0.000162	0.00264	CbGeAlD
Desipramine—Vomiting—Rivastigmine—Alzheimer's disease	0.000162	0.00132	CcSEcCtD
Desipramine—CYP2E1—nervous system—Alzheimer's disease	0.000161	0.00263	CbGeAlD
Desipramine—Rash—Rivastigmine—Alzheimer's disease	0.00016	0.0013	CcSEcCtD
Desipramine—Dermatitis—Rivastigmine—Alzheimer's disease	0.00016	0.0013	CcSEcCtD
Desipramine—Headache—Rivastigmine—Alzheimer's disease	0.000159	0.0013	CcSEcCtD
Desipramine—Benazepril—ACE—Alzheimer's disease	0.000157	0.0335	CrCbGaD
Desipramine—Atomoxetine—HTR6—Alzheimer's disease	0.000156	0.0333	CrCbGaD
Desipramine—ABCB1—telencephalon—Alzheimer's disease	0.000156	0.00254	CbGeAlD
Desipramine—CYP2E1—central nervous system—Alzheimer's disease	0.000155	0.00254	CbGeAlD
Desipramine—Nausea—Memantine—Alzheimer's disease	0.000154	0.00126	CcSEcCtD
Desipramine—Mianserin—HTR6—Alzheimer's disease	0.000152	0.0326	CrCbGaD
Desipramine—CYP2E1—cerebellum—Alzheimer's disease	0.000152	0.00248	CbGeAlD
Desipramine—SLC22A5—brain—Alzheimer's disease	0.000151	0.00247	CbGeAlD
Desipramine—Nausea—Rivastigmine—Alzheimer's disease	0.000151	0.00123	CcSEcCtD
Desipramine—HTR2A—nervous system—Alzheimer's disease	0.00014	0.00229	CbGeAlD
Desipramine—Clomipramine—HTR6—Alzheimer's disease	0.000139	0.0298	CrCbGaD
Desipramine—Promethazine—CALM1—Alzheimer's disease	0.000137	0.0293	CrCbGaD
Desipramine—Nortriptyline—HTR6—Alzheimer's disease	0.000136	0.0291	CrCbGaD
Desipramine—Protriptyline—SLC6A4—Alzheimer's disease	0.000136	0.0291	CrCbGaD
Desipramine—HTR2A—central nervous system—Alzheimer's disease	0.000135	0.0022	CbGeAlD
Desipramine—HTR2A—cerebellum—Alzheimer's disease	0.000132	0.00215	CbGeAlD
Desipramine—CYP2B6—brain—Alzheimer's disease	0.000131	0.00215	CbGeAlD
Desipramine—CYP3A4—nervous system—Alzheimer's disease	0.00013	0.00212	CbGeAlD
Desipramine—HRH1—brain—Alzheimer's disease	0.000128	0.0021	CbGeAlD
Desipramine—CYP2D6—nervous system—Alzheimer's disease	0.000128	0.00209	CbGeAlD
Desipramine—CYP3A4—central nervous system—Alzheimer's disease	0.000125	0.00204	CbGeAlD
Desipramine—CYP2E1—brain—Alzheimer's disease	0.000123	0.00201	CbGeAlD
Desipramine—CYP2D6—central nervous system—Alzheimer's disease	0.000123	0.00201	CbGeAlD
Desipramine—Doxepin—HTR6—Alzheimer's disease	0.000122	0.0261	CrCbGaD
Desipramine—CYP2D6—cerebellum—Alzheimer's disease	0.00012	0.00196	CbGeAlD
Desipramine—Ethopropazine—BCHE—Alzheimer's disease	0.000119	0.0254	CrCbGaD
Desipramine—HTR2A—brain—Alzheimer's disease	0.000107	0.00175	CbGeAlD
Desipramine—Chlorpromazine—CALM1—Alzheimer's disease	0.000106	0.0227	CrCbGaD
Desipramine—CYP2D6—brain—Alzheimer's disease	9.77e-05	0.00159	CbGeAlD
Desipramine—Triflupromazine—BCHE—Alzheimer's disease	9.72e-05	0.0208	CrCbGaD
Desipramine—Protriptyline—CYP2D6—Alzheimer's disease	9.56e-05	0.0204	CrCbGaD
Desipramine—Chlorpromazine—HTR6—Alzheimer's disease	9.56e-05	0.0204	CrCbGaD
Desipramine—Imipramine—HTR6—Alzheimer's disease	9.51e-05	0.0203	CrCbGaD
Desipramine—Amitriptyline—HTR6—Alzheimer's disease	9.45e-05	0.0202	CrCbGaD
Desipramine—ABCB1—nervous system—Alzheimer's disease	9.19e-05	0.0015	CbGeAlD
Desipramine—ABCB1—central nervous system—Alzheimer's disease	8.85e-05	0.00144	CbGeAlD
Desipramine—ABCB1—cerebellum—Alzheimer's disease	8.65e-05	0.00141	CbGeAlD
Desipramine—Aprindine—CYP2D6—Alzheimer's disease	8.39e-05	0.0179	CrCbGaD
Desipramine—Epinastine—HTR2A—Alzheimer's disease	7.75e-05	0.0166	CrCbGaD
Desipramine—Epinastine—CYP2D6—Alzheimer's disease	7.08e-05	0.0151	CrCbGaD
Desipramine—ABCB1—brain—Alzheimer's disease	7.03e-05	0.00115	CbGeAlD
Desipramine—Maprotiline—HTR2A—Alzheimer's disease	6.67e-05	0.0143	CrCbGaD
Desipramine—Mequitazine—CYP2D6—Alzheimer's disease	6.67e-05	0.0143	CrCbGaD
Desipramine—Maprotiline—CYP2D6—Alzheimer's disease	6.1e-05	0.013	CrCbGaD
Desipramine—Atomoxetine—SLC6A4—Alzheimer's disease	5.97e-05	0.0128	CrCbGaD
Desipramine—Mianserin—SLC6A4—Alzheimer's disease	5.83e-05	0.0125	CrCbGaD
Desipramine—Acepromazine—HTR2A—Alzheimer's disease	5.39e-05	0.0115	CrCbGaD
Desipramine—Nortriptyline—PTGS1—Alzheimer's disease	5.38e-05	0.0115	CrCbGaD
Desipramine—Clomipramine—SLC6A4—Alzheimer's disease	5.33e-05	0.0114	CrCbGaD
Desipramine—Nortriptyline—SLC6A4—Alzheimer's disease	5.21e-05	0.0111	CrCbGaD
Desipramine—Trimipramine—SLC6A4—Alzheimer's disease	4.91e-05	0.0105	CrCbGaD
Desipramine—Chlorpromazine—BCHE—Alzheimer's disease	4.69e-05	0.01	CrCbGaD
Desipramine—Doxepin—SLC6A4—Alzheimer's disease	4.68e-05	0.01	CrCbGaD
Desipramine—Atomoxetine—HTR2A—Alzheimer's disease	4.59e-05	0.00981	CrCbGaD
Desipramine—Prochlorperazine—CYP2D6—Alzheimer's disease	4.53e-05	0.00969	CrCbGaD
Desipramine—Mianserin—HTR2A—Alzheimer's disease	4.48e-05	0.00958	CrCbGaD
Desipramine—Atomoxetine—CYP2D6—Alzheimer's disease	4.19e-05	0.00897	CrCbGaD
Desipramine—Clomipramine—HTR2A—Alzheimer's disease	4.1e-05	0.00877	CrCbGaD
Desipramine—Mianserin—CYP2D6—Alzheimer's disease	4.1e-05	0.00877	CrCbGaD
Desipramine—Nortriptyline—HTR2A—Alzheimer's disease	4.01e-05	0.00857	CrCbGaD
Desipramine—Trimipramine—HTR2A—Alzheimer's disease	3.77e-05	0.00807	CrCbGaD
Desipramine—Clomipramine—CYP2D6—Alzheimer's disease	3.75e-05	0.00802	CrCbGaD
Desipramine—Nortriptyline—CYP2D6—Alzheimer's disease	3.66e-05	0.00783	CrCbGaD
Desipramine—Imipramine—SLC6A4—Alzheimer's disease	3.64e-05	0.00778	CrCbGaD
Desipramine—Promethazine—HTR2A—Alzheimer's disease	3.63e-05	0.00777	CrCbGaD
Desipramine—Amitriptyline—SLC6A4—Alzheimer's disease	3.62e-05	0.00774	CrCbGaD
Desipramine—Doxepin—HTR2A—Alzheimer's disease	3.59e-05	0.00769	CrCbGaD
Desipramine—Trimipramine—CYP2D6—Alzheimer's disease	3.45e-05	0.00738	CrCbGaD
Desipramine—Promethazine—CYP2D6—Alzheimer's disease	3.32e-05	0.0071	CrCbGaD
Desipramine—Doxepin—CYP2D6—Alzheimer's disease	3.29e-05	0.00703	CrCbGaD
Desipramine—Promazine—HTR2A—Alzheimer's disease	3.19e-05	0.00683	CrCbGaD
Desipramine—Chlorpromazine—HTR2A—Alzheimer's disease	2.81e-05	0.00601	CrCbGaD
Desipramine—Imipramine—HTR2A—Alzheimer's disease	2.8e-05	0.00598	CrCbGaD
Desipramine—Amitriptyline—HTR2A—Alzheimer's disease	2.78e-05	0.00594	CrCbGaD
Desipramine—Chlorpromazine—CYP2D6—Alzheimer's disease	2.57e-05	0.0055	CrCbGaD
Desipramine—Imipramine—CYP2D6—Alzheimer's disease	2.56e-05	0.00547	CrCbGaD
Desipramine—Amitriptyline—CYP2D6—Alzheimer's disease	2.54e-05	0.00544	CrCbGaD
Desipramine—CHRM4—Signaling by GPCR—IL6—Alzheimer's disease	2.51e-06	2.96e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	2.51e-06	2.95e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—F2—Alzheimer's disease	2.5e-06	2.94e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	2.49e-06	2.93e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.49e-06	2.93e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.49e-06	2.93e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.48e-06	2.92e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—LPL—Alzheimer's disease	2.48e-06	2.92e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.48e-06	2.91e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NOTCH1—Alzheimer's disease	2.47e-06	2.9e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	2.46e-06	2.9e-05	CbGpPWpGaD
Desipramine—CHRM5—GPCR downstream signaling—AKT1—Alzheimer's disease	2.45e-06	2.88e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	2.45e-06	2.88e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	2.44e-06	2.88e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—CASP3—Alzheimer's disease	2.42e-06	2.85e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—LPL—Alzheimer's disease	2.42e-06	2.85e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—IL6—Alzheimer's disease	2.41e-06	2.83e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PPARG—Alzheimer's disease	2.4e-06	2.82e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—NOS3—Alzheimer's disease	2.4e-06	2.82e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	2.39e-06	2.81e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	2.39e-06	2.81e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	2.37e-06	2.79e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PTGS2—Alzheimer's disease	2.37e-06	2.79e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	2.36e-06	2.77e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	2.35e-06	2.77e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—INS—Alzheimer's disease	2.35e-06	2.77e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PPARG—Alzheimer's disease	2.35e-06	2.76e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—INS—Alzheimer's disease	2.34e-06	2.75e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	2.34e-06	2.75e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PTGS2—Alzheimer's disease	2.34e-06	2.75e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	2.34e-06	2.75e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	2.33e-06	2.74e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	2.33e-06	2.74e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—MAPK8—Alzheimer's disease	2.33e-06	2.74e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	2.32e-06	2.73e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—AKT1—Alzheimer's disease	2.32e-06	2.73e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	2.32e-06	2.73e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	2.32e-06	2.72e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	2.31e-06	2.72e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	2.3e-06	2.71e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—INS—Alzheimer's disease	2.3e-06	2.71e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	2.3e-06	2.71e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—INS—Alzheimer's disease	2.3e-06	2.71e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—INS—Alzheimer's disease	2.3e-06	2.7e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	2.3e-06	2.7e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	2.29e-06	2.7e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—INS—Alzheimer's disease	2.29e-06	2.7e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—INS—Alzheimer's disease	2.28e-06	2.69e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—LPL—Alzheimer's disease	2.28e-06	2.68e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	2.27e-06	2.68e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	2.27e-06	2.67e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	2.27e-06	2.66e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—INS—Alzheimer's disease	2.26e-06	2.66e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	2.26e-06	2.66e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	2.25e-06	2.65e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	2.25e-06	2.64e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.24e-06	2.63e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.24e-06	2.63e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	2.23e-06	2.63e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	2.23e-06	2.62e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—MAPK8—Alzheimer's disease	2.23e-06	2.62e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	2.23e-06	2.62e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	2.22e-06	2.62e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—AKT1—Alzheimer's disease	2.22e-06	2.61e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	2.22e-06	2.61e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	2.21e-06	2.6e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.19e-06	2.58e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PTGS2—Alzheimer's disease	2.19e-06	2.58e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	2.19e-06	2.57e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	2.18e-06	2.56e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—VEGFA—Alzheimer's disease	2.15e-06	2.53e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	2.12e-06	2.5e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	2.11e-06	2.49e-05	CbGpPWpGaD
Desipramine—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.1e-06	2.47e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CALM1—Alzheimer's disease	2.09e-06	2.45e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—APOE—Alzheimer's disease	2.08e-06	2.45e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	2.08e-06	2.44e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	2.08e-06	2.44e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	2.06e-06	2.43e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—NOS3—Alzheimer's disease	2.06e-06	2.42e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	2.06e-06	2.42e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—VEGFA—Alzheimer's disease	2.06e-06	2.42e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.05e-06	2.42e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	2.05e-06	2.42e-05	CbGpPWpGaD
Desipramine—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	2.05e-06	2.41e-05	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—AKT1—Alzheimer's disease	2.04e-06	2.4e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CALM1—Alzheimer's disease	2.04e-06	2.4e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	2.03e-06	2.39e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—APOE—Alzheimer's disease	2.03e-06	2.39e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	2.02e-06	2.38e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—NOS3—Alzheimer's disease	2.02e-06	2.38e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	2.02e-06	2.37e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	2.02e-06	2.37e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CAV1—Alzheimer's disease	2.01e-06	2.37e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	2.01e-06	2.36e-05	CbGpPWpGaD
Desipramine—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	2e-06	2.36e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	2e-06	2.36e-05	CbGpPWpGaD
Desipramine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.99e-06	2.35e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	1.99e-06	2.34e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	1.98e-06	2.33e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	1.98e-06	2.32e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	1.97e-06	2.32e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TGFB1—Alzheimer's disease	1.97e-06	2.32e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	1.96e-06	2.31e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.96e-06	2.31e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.93e-06	2.27e-05	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—AKT1—Alzheimer's disease	1.93e-06	2.27e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.92e-06	2.26e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.91e-06	2.25e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	1.91e-06	2.24e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	1.9e-06	2.24e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.9e-06	2.24e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.89e-06	2.23e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TGFB1—Alzheimer's disease	1.89e-06	2.22e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	1.89e-06	2.22e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	1.87e-06	2.2e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	1.86e-06	2.19e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	1.85e-06	2.17e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.83e-06	2.15e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.82e-06	2.14e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.82e-06	2.14e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	1.81e-06	2.13e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.81e-06	2.13e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—INS—Alzheimer's disease	1.78e-06	2.09e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.77e-06	2.08e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	1.76e-06	2.07e-05	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.76e-06	2.07e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.74e-06	2.05e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.74e-06	2.05e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—INS—Alzheimer's disease	1.73e-06	2.04e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.73e-06	2.04e-05	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.73e-06	2.04e-05	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.73e-06	2.03e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	1.72e-06	2.03e-05	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.72e-06	2.03e-05	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	1.72e-06	2.02e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	1.72e-06	2.02e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	1.71e-06	2.01e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	1.71e-06	2.01e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	1.7e-06	2.01e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	1.7e-06	2e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	1.7e-06	2e-05	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.7e-06	2e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	1.7e-06	1.99e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	1.69e-06	1.99e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.69e-06	1.98e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	1.68e-06	1.98e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.68e-06	1.97e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	1.67e-06	1.97e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.67e-06	1.96e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.64e-06	1.93e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—INS—Alzheimer's disease	1.63e-06	1.92e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.63e-06	1.92e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.63e-06	1.91e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—Alzheimer's disease	1.62e-06	1.91e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.62e-06	1.91e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	1.62e-06	1.9e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.61e-06	1.89e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.6e-06	1.89e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.6e-06	1.88e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	1.58e-06	1.86e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.58e-06	1.85e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	1.57e-06	1.85e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.57e-06	1.85e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	1.57e-06	1.85e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.57e-06	1.84e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.56e-06	1.84e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	1.56e-06	1.84e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	1.56e-06	1.83e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	1.56e-06	1.83e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—Alzheimer's disease	1.55e-06	1.83e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.55e-06	1.82e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.55e-06	1.82e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.54e-06	1.82e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.54e-06	1.81e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.52e-06	1.79e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.49e-06	1.75e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IL6—Alzheimer's disease	1.49e-06	1.75e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.48e-06	1.74e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.46e-06	1.71e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	1.45e-06	1.71e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.45e-06	1.7e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	1.44e-06	1.7e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.43e-06	1.69e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	1.43e-06	1.68e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.42e-06	1.68e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IL6—Alzheimer's disease	1.42e-06	1.67e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.41e-06	1.66e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.39e-06	1.64e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—INS—Alzheimer's disease	1.38e-06	1.63e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—AKT1—Alzheimer's disease	1.37e-06	1.61e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.36e-06	1.6e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.34e-06	1.58e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.34e-06	1.57e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1.33e-06	1.57e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	1.33e-06	1.57e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.33e-06	1.56e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	1.32e-06	1.56e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—AKT1—Alzheimer's disease	1.31e-06	1.54e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	1.31e-06	1.54e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.31e-06	1.54e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	1.3e-06	1.53e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—AKT1—Alzheimer's disease	1.28e-06	1.5e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.27e-06	1.5e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.27e-06	1.49e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.25e-06	1.48e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.25e-06	1.47e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.24e-06	1.46e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	1.22e-06	1.43e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.21e-06	1.43e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—AKT1—Alzheimer's disease	1.19e-06	1.4e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	1.19e-06	1.4e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—AKT1—Alzheimer's disease	1.17e-06	1.38e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	1.17e-06	1.37e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.16e-06	1.36e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	1.12e-06	1.32e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	1.12e-06	1.32e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.11e-06	1.31e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—AKT1—Alzheimer's disease	1.1e-06	1.3e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	1.1e-06	1.29e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	1.1e-06	1.29e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—Alzheimer's disease	1.1e-06	1.29e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	1.09e-06	1.29e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	1.09e-06	1.28e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.09e-06	1.28e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	1.08e-06	1.27e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	1.08e-06	1.26e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.07e-06	1.26e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—INS—Alzheimer's disease	1.07e-06	1.26e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	1.02e-06	1.2e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	1.01e-06	1.18e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL6—Alzheimer's disease	1e-06	1.18e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	1e-06	1.18e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	9.98e-07	1.17e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	9.89e-07	1.16e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—AKT1—Alzheimer's disease	9.47e-07	1.11e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	9.44e-07	1.11e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	9.37e-07	1.1e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	9.29e-07	1.09e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—AKT1—Alzheimer's disease	9.28e-07	1.09e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	9.27e-07	1.09e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	9.24e-07	1.09e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	9.21e-07	1.08e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	9.12e-07	1.07e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	8.57e-07	1.01e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	7.16e-07	8.42e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—AKT1—Alzheimer's disease	6.99e-07	8.22e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	6.59e-07	7.75e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	5.58e-07	6.56e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	4.31e-07	5.07e-06	CbGpPWpGaD
